# ORal anticoaGulants in diAbetic and Nondiabetic Patients With nOn-valvular Atrial fibrillatioN (ORGANON)

> **NCT02935855** · PHASE4 · COMPLETED · sponsor: **University of Pavia** · enrollment: 300 (actual)

## Conditions studied

- Diabetes

## Interventions

- **DRUG:** Dabigatran
- **DRUG:** Apixaban
- **DRUG:** Rivaroxaban
- **DRUG:** Edoxaban
- **DRUG:** Warfarin
- **DRUG:** Acenocumarole

## Key facts

- **NCT ID:** NCT02935855
- **Lead sponsor:** University of Pavia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2019-04
- **Final completion:** 2019-09
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2020-11-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02935855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02935855, "ORal anticoaGulants in diAbetic and Nondiabetic Patients With nOn-valvular Atrial fibrillatioN (ORGANON)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02935855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*